Recent advances in nanozyme-CRISPR/Cas biosensors

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• The CRISPR/Cas system offers precise DNA targeting and cleavage, making it valuable for biosensing.
• Nanozymes, artificial enzymes with nanomaterial properties, enhance catalytic efficiency and target binding in biosensors.
• Integrating nanozymes with CRISPR/Cas systems significantly boosts biosensing performance.

Purpose of the Study:

• To review recent advancements in nanozyme-enhanced CRISPR/Cas biosensing strategies.
• To highlight bioanalytical applications of these integrated systems.
• To discuss challenges and future prospects for improved biosensor design.

Main Methods:

• Comprehensive literature review of nanozyme-enhanced CRISPR/Cas biosensing.
• Analysis of strategies for improving detection sensitivity and expanding sensing modes.
• Assessment of applications in detecting nucleic acids, proteins, and small molecules.

Main Results:

• Nanozyme integration substantially improves CRISPR/Cas biosensor sensitivity.
• Potential for direct target detection without pre-amplification is demonstrated.
• Enhanced biosensors show promise for precise, rapid, on-site bioanalysis.

Conclusions:

• Nanozyme-enhanced CRISPR/Cas biosensors represent a significant advancement in bioanalysis.
• Future research should focus on overcoming current challenges for next-generation biosensor development.
• These biosensors hold potential for diverse clinical sample analysis.